| ¿µ¹® | methotrexate | ÇÑ±Û | ¸ÞÅ䯮·º¼¼ÀÌÆ® |
|---|---|---|---|
| ¼³¸í | µî°¥»öÀÇ °áÁ¤¼º ºÐ¸». ¿±»ê´ëÇ×Á¦À̸ç Ç×Á¾¾çÁ¦·Î¼ ±Þ¼º ¹× ¾Æ±Þ¼º ¹éÇ÷º´, ¼ö¸·¹éÇ÷º´, Àӽżº À¶¸ð¾Ï, À¶¸ð¸·»ùÁ¾, Æ÷µµ¸ð¾ç±âÅÂ, °¢¼º¸²ÇÁÁ¾ÁøÇà±âÀÇ Ä¡·á¿¡ »ç¿ëµÇ¸ç ¶ÇÇÑ ÇװǼ±Á¦·Î »ç¿ëµÈ´Ù. °æ±¸Åõ¿© ¶Ç´Â ±ÙÀ°ÁÖ»çÇÑ´Ù. ¸é¿ª¾ïÁ¦Á¦·Î¼ ¸é¿ª¸Å°³ º´¿¡µµ »ç¿ëµÈ´Ù. |
||
| PVL | perivalvular leakage; permanent vision loss |
|---|---|
| CAMP | Cyclophosphamide, Adriamycin(Doxorubicin), Methotrexate, Procarbazine |
| MTX | MethoTreXate |
| MVAC | Methotrexate, Vinblastin, Adriamycin(= Doxorubicin), Cisplatin |
| ACM | acetaminophen; acute cerebrospinal meningitis; Adriamycin, cyclophosphamide, methotrexate; albumin- ... |
| PVL | Panton-Valentine leucocidin |
|---|---|
| PVL | Periventricular leucomalacia |
| PVL | Plasma viral load |
| PVL | Portal-vein ligation |
| PVL | portal vein ligated |
| methotrexate | <drug> Analogue of dihydrofolate. Inhibits dihydrofolate reductase and kills rapidly growing cells. Therapeutic agent for leukaemias, but has a low therapeutic ratio. (18 Nov 1997) |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
ÆÄ¸¶½Ã¾Æ¾Øµå¾÷ÁÔ¸ÞÅ䯮·º¼¼ÀÌÆ®ÁÖ25mg/ml(2ml) - »õâ
|
ÆÄ¸¶½Ã¾ÆÄÚ¸®¾Æ |
W00750051 | Methotrexate | Àü¹®ÀǾàǰ | »èÁ¦ | ºÐ¾÷¿¹¿ÜÀǾàǰ |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|